A Small-Particle Aerosol Model of Ebolavirus Zaire Infection in Ferrets.
Courtney A Cohen, Elizabeth E Zumbrun, James V Writer, Luke G Bonagofski, Charles J Shoemaker, Xiankun Zeng, Candace D Blancett, Christina E Douglas, Korey L Delp, Cheryl L Taylor-Howell, Brian D Carey, Suma Ravulapalli, Jo Lynne Raymond, John M Dye, Andrew S Herbert
Author Information
Courtney A Cohen: Viral Immunology Branch, Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. ORCID
Elizabeth E Zumbrun: Viral Immunology Branch, Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
James V Writer: Regulated Research Administration Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Luke G Bonagofski: Viral Immunology Branch, Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Charles J Shoemaker: Diagnostics System Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Xiankun Zeng: Pathology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Candace D Blancett: Diagnostics System Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Christina E Douglas: Diagnostics System Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Korey L Delp: Diagnostics System Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Cheryl L Taylor-Howell: Diagnostics System Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. ORCID
Brian D Carey: Diagnostics System Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. ORCID
Suma Ravulapalli: Diagnostics System Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Jo Lynne Raymond: Pathology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
John M Dye: Viral Immunology Branch, Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA.
Andrew S Herbert: Viral Immunology Branch, Virology Division, U.S. Army Medical Research Institute of Infectious Diseases, Frederick, MD 21702, USA. ORCID
The Ebola virus (EBOV) causes severe disease in humans, and animal models are needed to evaluate the efficacy of vaccines and therapeutics. While non-human primate (NHP) and rodent EBOV infection models have been well characterized, there is a growing need for an intermediate model. Here, we provide the first report of a small-particle aerosol (AE) EBOV ferret model and disease progression compared with the intramuscular (IM) EBOV ferret model. EBOV infection of ferrets by either route resulted in uniform lethality in 5-6.5 days post infection (dpi) in a dose-dependent manner, with IM-infected ferrets succumbing significantly earlier than AE-infected ferrets. EBOV disease progression differed between AE and IM routes, with significant viremia and presence of virus in target organs occurring earlier in the AE model. In contrast, significant fever, clinical signs of disease, liver pathology, and systemic inflammation occurred earlier in the IM EBOV model. Hepatocellular damage and splenic pathology were noted in both models, while pronounced lung pathology and renal impairment were exclusive to the AE and IM models, respectively. These results demonstrate that small-particle AE and IM ferret EBOV models share numerous common features with NHP and human EBOV infection by these routes and will therefore be useful for the development of vaccine and therapeutic countermeasures.
